Centre Hospitalier Universitaire de Saint Etienne Clinical Trials
Sponsors / Centre Hospitalier Universitaire de Saint Etienne
Centre Hospitalier Universitaire de Saint Etienne is listed as the lead sponsor on 556 clinical trials registered with ClinicalTrials.gov. 99 trials are actively recruiting participants, 9 remain active without open enrollment, and 318 have concluded. 100 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 861,792 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
Termination reasons: Other70% · Recruitment23% · Funding3% · Business2% · Safety1% · PI/or_Site1%
Recent Terminations
- Healthy"Official premature termination is failure to be included in the marathon group."
- Anorexia Nervosa"The sponsor received the following instruction from the ANSM : The sponsor shall conduct toxicity studies in accordance with the applicable guidelines, in particular ICH guideline M3 (R2) on non-clinical safety studies for the conduct of h"
- Muscle Spasticity"Lack of inclusion"
- Healthy Athletes"inclusion rate too low"
- Anorexia Nervosa"The coordinating investigator left the sponsor institution and has not been replaced."
- Bleeding"Only one patient was included in this study due to overly restrictive inclusion and exclusion criteria."
- Aging"Lack of enrollments"
- Healthy Ageing"The training protocol in place is not sufficiently adapted to older people"
- NCT05258929 Stopped Jun 2022Allograft"low inclusion rate"
- NCT05124574 Stopped Mar 2022SARS-COV-2 Infection"No cases of COVID recorded in maternity wards since April 2022"
Active Trials (9 total)
- NCT05323474
- NCT07504003
- NCT06175091
- NCT07455994
- Bone Loss NANCT06541548
- NCT05893030
- Cancer NANCT06386107
- NCT07355790
- NCT07322276
- NCT07207642
- NCT06945081
- Flu Vaccine PHASE4NCT06824779
- NCT02670447
- NCT07073703
- NCT06931509
- NCT05780762
- NCT05945212
- Anti-MAG Neuropathy PHASE3NCT05136976
- NCT05340023
- NCT05739565